Diasorin Inc 1951 Northwestern Avenuestillwater Mn 55082 0285 Pma Numberp180047 Supplement Numbers022 Date Received11 10 2022 Decision Date12 08 2022 Product Code Ncd Advisory Committee Microbiology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Diasorin Inc 1951 Northwestern Avenuestillwater Mn 55082 0285 Pma Numberp180047 Supplement Numbers022 Date Received11 10 2022 Decision Date12 08 2022 Product Code Ncd Advisory Committee Microbiology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
DiaSorin, Inc.1951 Northwestern Avenuestillwater, MN 55082-0285 PMA NumberP180047 Supplement NumberS022 Date Received11/10/2022 Decision Date12/08/2022 Product Code NCD  Advisory Committee Microbiology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
LIAISON® QuantiFERON®-TB Gold Plus and LIAISON® XL Control QuantiFERON®-TB Gold Plus2022-12-08

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.